Insight

Jul 13, 2024, 19:41

Joshua Zeidner: Subset analyses from QUAZAR study

Joshua Zeidner, Associate Professor at UNC Lineberger, shared on X about a recent paper by Hartmut Döhner et al. titled “Prognostic impact of NPM1 and FLT3 mutations in patients with AML in first remission treated with oral azacitidine” published in ASH Publications.

Authors: Hartmut Döhner, Andrew H. Wei, Gail J. Roboz, Pau Montesinos, Felicitas R. Thol, Farhad Ravandi, Hervé Dombret, Kimmo Porkka, Irwindeep Sandhu, Barry Skikne, Wendy L. See, Manuel Ugidos, Alberto Risueño, Esther T. Chan, Anjan Thakurta, C.L. Beach, Daniel Lopes de Menezes.

Joshua Zeidner commented on X sharing this paper:

“Leukemia Journal Club Happy Hour tackled maintenance therapy with oral Azacitidine in NPM1 mutated AML patients- subset analyses from QUAZAR study- Great discussion with colleagues over.” ․

Source: Joshua Zeidner/X

Alberto Risueño AML Andrew Wei Anjan Thakurta ASH Publications azacitidine Barry Skikne cancer Daniel Lopes de Menezes Esther Chan Farhad Ravandi Felicitas Thol Gail Roboz Hartmut Döhner Hervé Dombret Irwindeep Sandhu Joshua Zeidner Kimmo Porkka Leukemia Leukemia Journal Club Manuel Ugidos NPM1 NPM1 mutation OncoDaily Oncology Pau Montesinos QUAZAR UNC Lineberger Wendy See

In Memory of Alan Rickman and His Battle with Prostate and Pancreatic Cancer

New Paper Alert: Systemic management of advanced HCC: an increasingly complex game

AC-satoreotide got FDA Orphan Drug Designation status for SCLC and MCC

Oncologist Near Me – Nazik Hammad: A Leader in Cancer Care, Medical Education, and Health Equity

Garo Armen - A Bold Call to Action: Embracing Real-Time Innovation in Pediatric Cancer